{"id":43647,"date":"2025-10-17T13:18:15","date_gmt":"2025-10-17T05:18:15","guid":{"rendered":"https:\/\/flcube.com\/?p=43647"},"modified":"2025-10-17T13:18:16","modified_gmt":"2025-10-17T05:18:16","slug":"astrazeneca-china-integrates-symbicort-and-breztri-sales-teams-in-new-organizational-shake%e2%80%91up","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=43647","title":{"rendered":"AstraZeneca China Integrates Symbicort and Breztri Sales Teams in New Organizational Shake\u2011Up"},"content":{"rendered":"\n<p><strong>AstraZeneca<\/strong> (AZ; <a href=\"https:\/\/www.google.com\/finance\/quote\/AZN:NASDAQ\">NASDAQ: AZN<\/a>)\u00a0announced a strategic re\u2011alignment of its respiratory inhalation portfolio in China, consolidating the sales operations for <strong>Symbicort<\/strong> and <strong>Breztri<\/strong> under a single management umbrella. The move, revealed by William Tong, Assistant Vice\u2011President and Head of the Respiratory Inhalation Business Unit, aims to streamline go\u2011to\u2011market activities, accelerate product uptake, and strengthen cross\u2011functional collaboration across the region.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-personnel-changes\">Personnel Changes<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>New Role<\/th><th>New Appointee<\/th><th>Previous Title &amp; Region<\/th><th>Report To<\/th><\/tr><\/thead><tbody><tr><td>Executive Director, Symbicort National Marketing<\/td><td><strong>Yu\u202fJunping<\/strong><\/td><td>Executive Director, Symbicort East Region<\/td><td>William Tong<\/td><\/tr><tr><td>Head of Respiratory Inhalation Sales Operations<\/td><td><strong>Wang\u202fChengfeng<\/strong><\/td><td>Acting Sales Director, Breztri East Region<\/td><td>William Tong<\/td><\/tr><tr><td>National Marketing Director, Symbicort (Outgoing)<\/td><td><strong>Zhong\u202fYing<\/strong><\/td><td>\u2013<\/td><td>\u2013<\/td><\/tr><tr><td>\u2013<\/td><td>\u2013<\/td><td>\u2013<\/td><td>\u2013<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Zhong\u202fYing<\/strong> will depart AstraZeneca China on <strong>October\u202f20,\u202f2025<\/strong> to pursue external opportunities.<\/li>\n\n\n\n<li><strong>Yu\u202fJunping<\/strong> and <strong>Wang\u202fChengfeng<\/strong> will assume dual reporting to William Tong, reinforcing a unified sales strategy for both inhalers.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale\">Strategic Rationale<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Unified Brand Presence<\/strong> \u2013 Combining Symbicort\u2019s well\u2011established asthma\/COPD portfolio with Breztri\u2019s emerging triple\u2011therapy platform creates a coherent respiratory offering that can be leveraged across physician segments.<\/li>\n\n\n\n<li><strong>Operational Efficiency<\/strong> \u2013 Shared sales resources, joint field training, and consolidated customer insights reduce duplication and accelerate product penetration.<\/li>\n\n\n\n<li><strong>Market Responsiveness<\/strong> \u2013 A single, agile sales organelle enables AstraZeneca China to adapt quickly to payer negotiations, emerging competitive dynamics, and evolving clinical guidelines.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-forward-looking-statements\">Forward\u2011Looking Statements<\/h3>\n\n\n\n<p>This release contains forward\u2011looking statements that involve risks and uncertainties. Actual results may differ materially.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AstraZeneca (AZ; NASDAQ: AZN)\u00a0announced a strategic re\u2011alignment of its respiratory inhalation portfolio in China, consolidating&#8230;<\/p>\n","protected":false},"author":1,"featured_media":43648,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[130,871],"class_list":["post-43647","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","tag-astrazeneca","tag-nasdaq-azn"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>AstraZeneca China Integrates Symbicort and Breztri Sales Teams in New Organizational Shake\u2011Up - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"AstraZeneca (AZ; NASDAQ: AZN)\u00a0announced a strategic re\u2011alignment of its respiratory inhalation portfolio in China, consolidating the sales operations for Symbicort and Breztri under a single management umbrella. The move, revealed by William Tong, Assistant Vice\u2011President and Head of the Respiratory Inhalation Business Unit, aims to streamline go\u2011to\u2011market activities, accelerate product uptake, and strengthen cross\u2011functional collaboration across the region.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=43647\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AstraZeneca China Integrates Symbicort and Breztri Sales Teams in New Organizational Shake\u2011Up\" \/>\n<meta property=\"og:description\" content=\"AstraZeneca (AZ; NASDAQ: AZN)\u00a0announced a strategic re\u2011alignment of its respiratory inhalation portfolio in China, consolidating the sales operations for Symbicort and Breztri under a single management umbrella. The move, revealed by William Tong, Assistant Vice\u2011President and Head of the Respiratory Inhalation Business Unit, aims to streamline go\u2011to\u2011market activities, accelerate product uptake, and strengthen cross\u2011functional collaboration across the region.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=43647\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-17T05:18:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-17T05:18:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1702.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43647#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43647\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"AstraZeneca China Integrates Symbicort and Breztri Sales Teams in New Organizational Shake\u2011Up\",\"datePublished\":\"2025-10-17T05:18:15+00:00\",\"dateModified\":\"2025-10-17T05:18:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43647\"},\"wordCount\":254,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43647#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1702.webp\",\"keywords\":[\"AstraZeneca\",\"NASDAQ: AZN\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43647#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43647\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=43647\",\"name\":\"AstraZeneca China Integrates Symbicort and Breztri Sales Teams in New Organizational Shake\u2011Up - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43647#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43647#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1702.webp\",\"datePublished\":\"2025-10-17T05:18:15+00:00\",\"dateModified\":\"2025-10-17T05:18:16+00:00\",\"description\":\"AstraZeneca (AZ; NASDAQ: AZN)\u00a0announced a strategic re\u2011alignment of its respiratory inhalation portfolio in China, consolidating the sales operations for Symbicort and Breztri under a single management umbrella. The move, revealed by William Tong, Assistant Vice\u2011President and Head of the Respiratory Inhalation Business Unit, aims to streamline go\u2011to\u2011market activities, accelerate product uptake, and strengthen cross\u2011functional collaboration across the region.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43647#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43647\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43647#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1702.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1702.webp\",\"width\":1080,\"height\":608,\"caption\":\"AstraZeneca China Integrates Symbicort and Breztri Sales Teams in New Organizational Shake\u2011Up\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43647#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AstraZeneca China Integrates Symbicort and Breztri Sales Teams in New Organizational Shake\u2011Up\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AstraZeneca China Integrates Symbicort and Breztri Sales Teams in New Organizational Shake\u2011Up - Insight, China&#039;s Pharmaceutical Industry","description":"AstraZeneca (AZ; NASDAQ: AZN)\u00a0announced a strategic re\u2011alignment of its respiratory inhalation portfolio in China, consolidating the sales operations for Symbicort and Breztri under a single management umbrella. The move, revealed by William Tong, Assistant Vice\u2011President and Head of the Respiratory Inhalation Business Unit, aims to streamline go\u2011to\u2011market activities, accelerate product uptake, and strengthen cross\u2011functional collaboration across the region.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=43647","og_locale":"en_US","og_type":"article","og_title":"AstraZeneca China Integrates Symbicort and Breztri Sales Teams in New Organizational Shake\u2011Up","og_description":"AstraZeneca (AZ; NASDAQ: AZN)\u00a0announced a strategic re\u2011alignment of its respiratory inhalation portfolio in China, consolidating the sales operations for Symbicort and Breztri under a single management umbrella. The move, revealed by William Tong, Assistant Vice\u2011President and Head of the Respiratory Inhalation Business Unit, aims to streamline go\u2011to\u2011market activities, accelerate product uptake, and strengthen cross\u2011functional collaboration across the region.","og_url":"https:\/\/flcube.com\/?p=43647","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-17T05:18:15+00:00","article_modified_time":"2025-10-17T05:18:16+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1702.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=43647#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=43647"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"AstraZeneca China Integrates Symbicort and Breztri Sales Teams in New Organizational Shake\u2011Up","datePublished":"2025-10-17T05:18:15+00:00","dateModified":"2025-10-17T05:18:16+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=43647"},"wordCount":254,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=43647#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1702.webp","keywords":["AstraZeneca","NASDAQ: AZN"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=43647#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=43647","url":"https:\/\/flcube.com\/?p=43647","name":"AstraZeneca China Integrates Symbicort and Breztri Sales Teams in New Organizational Shake\u2011Up - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=43647#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=43647#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1702.webp","datePublished":"2025-10-17T05:18:15+00:00","dateModified":"2025-10-17T05:18:16+00:00","description":"AstraZeneca (AZ; NASDAQ: AZN)\u00a0announced a strategic re\u2011alignment of its respiratory inhalation portfolio in China, consolidating the sales operations for Symbicort and Breztri under a single management umbrella. The move, revealed by William Tong, Assistant Vice\u2011President and Head of the Respiratory Inhalation Business Unit, aims to streamline go\u2011to\u2011market activities, accelerate product uptake, and strengthen cross\u2011functional collaboration across the region.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=43647#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=43647"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=43647#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1702.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1702.webp","width":1080,"height":608,"caption":"AstraZeneca China Integrates Symbicort and Breztri Sales Teams in New Organizational Shake\u2011Up"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=43647#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"AstraZeneca China Integrates Symbicort and Breztri Sales Teams in New Organizational Shake\u2011Up"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1702.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43647","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=43647"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43647\/revisions"}],"predecessor-version":[{"id":43649,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43647\/revisions\/43649"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/43648"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=43647"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=43647"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=43647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}